AptarGroup (NYSE:ATR) Updates Q2 2024 Earnings Guidance

AptarGroup (NYSE:ATR) issued an update on its second quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 1.300-1.380 for the period, compared to the consensus earnings per share estimate of 1.360. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the stock. Robert W. Baird upgraded shares of AptarGroup from a neutral rating to an outperform rating and lifted their target price for the company from $125.00 to $150.00 in a research note on Wednesday, January 3rd. Wells Fargo & Company lifted their target price on shares of AptarGroup from $157.00 to $160.00 and gave the company an overweight rating in a research note on Thursday, March 7th.

AptarGroup Stock Performance

ATR stock traded up $0.25 on Thursday, reaching $140.26. 694,402 shares of the company were exchanged, compared to its average volume of 317,365. AptarGroup has a 12 month low of $111.63 and a 12 month high of $145.35. The stock’s fifty day moving average price is $140.75 and its 200 day moving average price is $131.92. The firm has a market capitalization of $9.28 billion, a PE ratio of 32.94, a PEG ratio of 3.85 and a beta of 0.59. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.24 and a quick ratio of 0.83.

AptarGroup (NYSE:ATR) last announced its earnings results on Friday, February 9th. The industrial products company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.09. The business had revenue of $838.48 million for the quarter, compared to analyst estimates of $842.50 million. AptarGroup had a net margin of 8.16% and a return on equity of 14.46%. AptarGroup’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 earnings per share. On average, research analysts anticipate that AptarGroup will post 5.21 EPS for the current fiscal year.

AptarGroup Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 16th. Investors of record on Thursday, April 25th will be given a dividend of $0.41 per share. The ex-dividend date of this dividend is Wednesday, April 24th. This represents a $1.64 annualized dividend and a yield of 1.17%. AptarGroup’s dividend payout ratio (DPR) is 38.59%.

Insider Buying and Selling

In other AptarGroup news, CEO Stephan B. Tanda sold 32,000 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $141.67, for a total transaction of $4,533,440.00. Following the transaction, the chief executive officer now directly owns 159,024 shares in the company, valued at approximately $22,528,930.08. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other AptarGroup news, CEO Stephan B. Tanda sold 32,000 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $141.67, for a total transaction of $4,533,440.00. Following the transaction, the chief executive officer now directly owns 159,024 shares in the company, valued at approximately $22,528,930.08. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gael Touya sold 3,500 shares of the company’s stock in a transaction dated Monday, March 11th. The shares were sold at an average price of $142.84, for a total transaction of $499,940.00. Following the transaction, the insider now owns 33,426 shares in the company, valued at $4,774,569.84. The disclosure for this sale can be found here. Insiders have sold a total of 37,500 shares of company stock worth $5,318,280 in the last 90 days. Corporate insiders own 1.00% of the company’s stock.

About AptarGroup

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.